RSS Feed
- Walmart vs. Costco: How Do They Really Compare?
- Putting a Fingerprint on Every Bullet
- Tim Cook Killed Apple One More Time This Week
- The Dramatically Improved Chevrolet Volt 2.0
- Will Apple Ever Release a New Product?
Article
Amicus Delays U.S. Approval Filing for Fabry Disease Drug
Amigal will not be filed with FDA until late 2014 or early 2015.
08:43AM 06/17/13
Article
Elan Shareholder Vote Nixes Royalty Pharma Takeover -- For Now
Royalty Pharma is going to court to re-instate its hostile tender offer for Elan following a shareholder vote.
07:44AM 06/17/13
Article
Elan Plants 'For Sale' Sign on Front Lawn
The latest twist in the contentious battle for Elan as it fights a takeover by Royalty Pharma.
09:52AM 06/14/13
Article
Wall Street Realizes Myriad Genetics Monopoly on Breast Cancer Risk Tests Is Done
Analyst downgrade Myriad following a Supreme Court ruling invalidating patents on human genese.
07:43AM 06/14/13
Article
Biotech Stock Mailbag: Exact Sciences, Questcor, Biotech M&A, Celsion
Biotech columnist Adam Feuerstein answers readers' questions about healthcare companies.
07:00AM 06/14/13
Article
These Mutated Cystic Fibrosis Cells Are Worth Billions to Vertex Pharma
A single data slide explains how Vertex will come to dominate cystic fibrosis therapy.
02:57PM 06/13/13
Article
Myriad Genetics Shares Rise on Supreme Court Gene Patent Ruling
The Court mixed ruling on the patenting of human genes preserves Myriad's cancer-testing business.
11:24AM 06/13/13
Article
Amgen Drug Delays Ovarian Cancer Re-Growth, Survival Benefit Unclear
Amgen may have a tough time getting FDA approval for trebananib without a survival benefit.
09:57AM 06/12/13
Article
Vertex's Roadmap to $10 Billion in Cystic Fibrosis Drug Sales
Combinations of various Vertex drugs could benefit 90% of cystic fibrosis patients.
09:00AM 06/11/13
Article
Five Best-Performing Biotech Stocks of 2013 (Some May Surprise You)
In a bubbly year for the biotech sector, these five stocks stand out over the rest.
07:00AM 06/11/13